BASEL, Switzerland, le 14 déc.
/PRNewswire/ - Neuro-Biotech Corp. (PINKSHEET: MRES) (OTCQB: MRES)
announced today having now reached debt free status, and currently
planning its distribution program for 2011.
After 2 years of hard work and administrative organisation to
finance and bring to market the distribution of its products,
Neuro-Biotech Corp. is proud to inform its shareholders that it has
repaid all debts to third parties totalling the sum of one million,
one hundred, twenty five thousand and nine hundred thirteen dollars ($
1,125,913).
"The team has been working non-stop to attain this level, and we
now have all green lights to begin a strategically planned series
of Scientific Speakerships and Road Shows in Europe and United
States."
For more information on Neuro-Biotech Products:
neuro-biotechcorp.com.
Forward Looking Statements
This release contains statements that are made pursuant to the Safe
Harbor Provisions of the Private Securities Litigation Act of 1995.
Certain statements in this press release may contain words such as
"anticipates," "believes," "could," "expects," "intends," "may,"
"projects," "targets" and other similar language that is considered
forward-looking statements. These forward-looking statements are
subject to certain risks and uncertainties and persons reading this
release are cautioned that such statements are only predictions,
and that the Company's actual future results or performance may be
materially different. The Company disclaims any intention or
obligation to update or revise forward-looking information, whether
as a result of new information, future events, or otherwise, could
cause the company's actual results to differ materially from those
indicated in any forward-looking statements.
SOURCE Neuro-Biotech Corp.
Copyright éc. PR Newswire